Clinical trial Recruiting at 1 site Interventional Ages 4 to 16

Improving asthma control in children through telemedicine education for caregivers

Official title: Effectiveness of Telemedicine-Based Education for Caregivers on Asthma Control in Children With Uncontrolled Asthma: A Randomized Controlled Trial

Run by Can Tho University of Medicine and Pharmacy · NCT06753214 · Data updated 2026-11-12

This study tests whether teaching caregivers about asthma through telemedicine can help children with uncontrolled asthma breathe better and manage their condition more effectively.

More Uncontrolled Asthma trials

Quick facts

Study typeInterventional
Ages4 Years to 16 Years
SexAll
Enrollment64 (estimated)
SponsorCan Tho University of Medicine and Pharmacy
Academic / other
Locations1 site (Can Tho)
StatusRecruiting
StartedJune 5, 2024
Main results expectedJune 2026
Study endsJune 2026
Registry record updatedJuly 8, 2025
Trial IDNCT06753214 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pediatric patients diagnosed with uncontrolled asthma according to GINA guidelines.

Probably not a fit

Patients who are unable to complete the necessary questionnaires or have siblings participating in the study may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on enhancing asthma management in pediatric patients with uncontrolled asthma by providing telemedicine-based education to their caregivers. The approach involves remote guidance and support to improve caregivers' knowledge and practices regarding asthma management. By utilizing telemedicine, the study aims to overcome geographical barriers and ensure that caregivers receive the necessary tools to help control their children's asthma effectively. The intervention will be compared to standard care to assess its effectiveness in improving asthma outcomes.

Why it matters

Potential benefit: If successful, this approach could lead to better asthma control and improved quality of life for children suffering from uncontrolled asthma.

How similar studies have gone: Other studies have shown promising results with telemedicine approaches in managing chronic conditions, suggesting potential success for this intervention.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pediatric asthma patients diagnosed according to the GINA guidelines, classified as having uncontrolled asthma, are managed and followed up for at least 1 month at the pediatric asthma unit of the outpatient department.

Exclusion Criteria:

* Pediatric patients who do not cooperate or are unable to complete the Childhood Asthma Control Test questionnaire.
* Caregivers who cannot complete the questionnaires related to the assessment of asthma control and associated factors.
* Pediatric patients who have siblings participating in the study.
* Patients currently participating in another clinical study (excluding non-interventional studies or registries).
* Failure to return for a second visit within 6 months following enrollment.

Where it's running

  • Can Tho Children's Hospital
    Can Tho, Vietnam
    Recruiting

Study contacts

  • Principal investigator: Thang Hoang Le, MD — Can Tho University of Medicine and Pharmacy
  • Study coordinator: Thang Hoang Le, MD
  • Email: hoangthang0899@gmail.com
  • Phone: +84962024776

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.